Posted in | Events & Awards

Blacktrace Holdings Ltd. to in-license PerkinElmer Technology

Published on August 8, 2014 at 10:24 AM

Blacktrace Holdings Limited, a leading group of companies focused on Productizing Science®, today announced that it has entered into a license agreement with PerkinElmer to license certain microfluidic technology owned by its subsidiary, Caliper Life Sciences, Inc., for a wide range of applications.

 The Blacktrace Group includes a number of well-known brands. Dolomite Microfluidics is a leading solution provider of systems and components such as: microfluidic droplet systems, microfluidic chips, pumps and connectors, as well as custom solutions and bespoke product development services. Syrris is a leader in chemistry tools, with the award winning 4th Generation Asia Flow Chemistry System being the most successful flow chemistry system ever.

The license provides Blacktrace with maximum flexibility as it expands its product ranges to include more microfluidic chips and technology, and develops new innovative platforms that will deliver superior performance to its customers worldwide. PerkinElmer continues to leverage its microfluidics portfolio through licensing collaborations to extend its market reach.

About Blacktrace Holdings Ltd

Blacktrace Holdings Ltd is a world leader in Productizing Science® headquartered in the United Kingdom, with sales offices based in the United States, Japan, India and Brazil. Blacktrace exploits its leading capabilities in product development, manufacturing, global marketing and sales through brands that address customers with common needs. The current brands of Blacktrace are Syrris (chemistry tools), Dolomite Microfluidics (microfluidic solutions), Glass Solutions (glass manufacturing) and Centeo (biology tools).

Productizing Science® is the subject of translating scientific discovery and invention into commercially successful products and services.

To find out more please see the Blacktrace website: www.blacktrace.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit